FIVE PRIME THERAPEUTICS, INC. 4 SEC Filings

Filed On	Filing
19 Apr 2021	Form 4: Sarena Francis Willard, Chief Strategy Officer Gave 3,825 shares as a gift · Acquired 2,385 shares (Gift) · Gave 2,460 shares as a gift · 4 more
19 Apr 2021	Form 4: Smith David V, Executive Vice President & CFO Received 66,000 shares as a grant or award · Returned 138,947 shares to the issuer ($5.28M) · Disposed of 365,000 Employee Stock Option (right to buy) (Disposition to Issuer)
19 Apr 2021	Form 4: Collins Helen Louise, EVP and Chief Medical Officer Gave 8,085 shares as a gift · Received 66,000 shares as a grant or award · Returned 135,547 shares to the issuer ($5.15M) · 1 more
19 Apr 2021	Form 4: White David, See Remarks Returned 33,423 shares to the issuer ($1.27M) · Disposed of 55,000 Employee Stock Option (right to buy) (Disposition to Issuer)
19 Apr 2021	Form 4: Ringo William R, Director Gave 10,000 shares as a gift · Disposed of 64,100 Stock Option (right to buy) (Disposition to Issuer) · Disposed of 340,352 Employee Stock Option (right to buy) (Disposition to Issuer)
19 Apr 2021	Form 4: Berger Franklin M, Director Returned 5,000 shares to the issuer ($190K) · Disposed of 67,500 Stock Option (right to buy) (Disposition to Issuer)
19 Apr 2021	Form 4: Dhingra Kapil, Director Disposed of 80,000 Stock Option (right to buy) (Disposition to Issuer)
19 Apr 2021	Form 4: Jensen Peder, Director Disposed of 80,000 Stock Option (right to buy) (Disposition to Issuer)
19 Apr 2021	Form 4: Nicholson Garry A, Director Disposed of 60,000 Stock Option (right to buy) (Disposition to Issuer)
19 Apr 2021	Form 4: Schafer Carol, Director Disposed of 46,250 Stock Option (right to buy) (Disposition to Issuer)
19 Apr 2021	Form 4: Lyons-Williams Lori, Director Disposed of 45,000 Stock Option (right to buy) (Disposition to Issuer)
19 Apr 2021	Form 4: Civik Thomas, Director Returned 68,971 shares to the issuer ($2.62M) · Disposed of 480,000 Employee Stock Option (right to buy) (Disposition to Issuer)
13 Apr 2021	Form 4: Civik Thomas, Director Gave up 11,088 shares to cover exercise price or tax ($421K)
02 Mar 2021	Form 4: Sarena Francis Willard, Chief Strategy Officer Gave up 1,158 shares to cover exercise price or tax ($25.7K)
02 Mar 2021	Form 4: Collins Helen Louise, EVP and Chief Medical Officer Gave up 1,158 shares to cover exercise price or tax ($25.7K)
02 Mar 2021	Form 4: White David, See Remarks Gave up 1,461 shares to cover exercise price or tax ($32.5K)
26 Feb 2021	Form 4: Sarena Francis Willard, Chief Strategy Officer Gave up 5,100 shares to cover exercise price or tax ($131K) · Gave up 1,653 shares to cover exercise price or tax ($38.2K)
26 Feb 2021	Form 4: Collins Helen Louise, EVP and Chief Medical Officer Gave up 5,091 shares to cover exercise price or tax ($131K) · Gave up 1,653 shares to cover exercise price or tax ($38.2K)
26 Feb 2021	Form 4: Smith David V, Executive Vice President & CFO Gave up 5,110 shares to cover exercise price or tax ($131K)
26 Feb 2021	Form 4: White David, See Remarks Gave up 1,155 shares to cover exercise price or tax ($29.7K)

Comments